The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, yielding billions in revenue , its patent expiration created a flood of knock-off medications, significantly eroding its market share . While specific businesses may seek to capitalize on male sexual dysfunction, the current